SpA Forum

المقدمة

سجل الان

The SpA Forum aims to provide healthcare professionals with scientific data on the pathophysiology, clinical management, and treatment optimization of PsA and AxSpa with expert led discussions highlighting the evidence of IL-17i effect on pain and inflammation mechanisms, disease progression from psoriasis to psoriatic arthritis, and clinical case scenarios to bridge theory with practical management.
The forum will foster regional experts to address unmet needs in multidisciplinary management, and patient-centered care, supporting best clinical practice and improved patient outcomes in PsA and AxSpa.

الأهداف

To clarify key inflammatory pathways and mechanisms underlying pain and disease progression in SpA
To educate HCPs about extra-musculoskeletal manifestations of PsA and AxSpA, and their impact on quality of life
To integrate holistic care strategies that address skin, joint, and systemic comorbidities to enhance patient outcomes

المتحدثين

Dr Aqeel Ghanem

.

Dr Ahmed Abogamal

.

Dr Ibrahim Alhomood

.

Dr Hanan Alrayes

.